THE DEAL, AT A GLANCE
From the announcementPraser Therapeutics
01Who is involvedBacked by No Limit Holdings, supported by ReforgeVC, angels Michael Egorov (Founder, Curve Finance)From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedPraser Therapeutics raised $50B Pre-Seed, announced 2026-07-16From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersPraser Therapeutics represents an outlier capital-allocation event in Healthcare & Life Sciences, with a Pre-Seed round reported at $50000M placing it at the 100th…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Praser Therapeutics · Financing Record
Explore source-linked visual explanations for Praser Therapeutics. Unsupported claims are withheld while source review continues.
Record 8277 · Recorded date: 2026-07-16
Explore company records →